J. David Boyle II
2009
In 2009, J. David Boyle II earned a total compensation of $564.7K as Chief Financial Officer and Secretary at Sarepta Therapeutics, a 33% decrease compared to previous year.
Compensation breakdown
| Bonus | $62,111 |
|---|---|
| Option Awards | $116,550 |
| Salary | $324,000 |
| Stock Awards | $42,579 |
| Other | $19,437 |
| Total | $564,677 |
Boyle received $324K in salary, accounting for 57% of the total pay in 2009.
Boyle also received $62.1K in bonus, $116.6K in option awards, $42.6K in stock awards and $19.4K in other compensation.
Rankings
In 2009, J. David Boyle II's compensation ranked 6,424th out of 9,885 executives tracked by ExecPay. In other words, Boyle earned more than 35.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,424 out of 9,885 | 35th |
Division Manufacturing | 2,345 out of 3,690 | 36th |
Major group Chemicals And Allied Products | 509 out of 866 | 41st |
Industry group Drugs | 344 out of 638 | 46th |
Industry Pharmaceutical Preparations | 245 out of 446 | 45th |
Source: SEC filing on May 4, 2010.
Boyle's colleagues
We found four more compensation records of executives who worked with J. David Boyle II at Sarepta Therapeutics in 2009.
2009
Leslie Hudson
Sarepta Therapeutics
Chief Executive Officer
2009
Stephen Shrewsbury
Sarepta Therapeutics
Chief Medical Officer
2009
Paul Medeiros
Sarepta Therapeutics
Senior Vice President of Business Development and Chief Business Officer
2009
Patrick Iversen
Sarepta Therapeutics